{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2,4-dinitrochlorobenzene", "Wikstroemia dolichantha", "atopic dermatitis", "oxazolone", "skin barrier function"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31018627", "DateCompleted": {"Year": "2019", "Month": "11", "Day": "19"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "04", "Day": "23"}], "Language": ["eng"], "ELocationID": ["914", "10.3390/nu11040914"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "11", "Issue": "4", "PubDate": {"Year": "2019", "Month": "Apr", "Day": "23"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Effect of Topically Applied <i>Wikstroemia dolichantha</i> Diels on the Development of Atopic Dermatitis-Like Skin Symptoms in Mice.", "Abstract": {"AbstractText": ["Plants of the genus <i>Wikstroemia</i> are traditionally used to treat inflammatory diseases like bronchitis and rheumatoid arthritis. In the present study, the anti-atopic effects of an EtOH extract of <i>Wikstroemia dolichantha</i> (WDE) on oxazolone- and DNCB (2,4-dinitrochlorobenzene)-induced dermatitis in mice were investigated. Both ears of BALB/c mice were exposed to oxazolone, and dorsal skins of SKH-1 hairless mice were sensitized with DNCB to induce acute eczematous atopic skin lesions. 1% WDE was applied daily to oxazolone- and DNCB-induced AD mice for two or three weeks, respectively. Total IL-4 and IgE concentrations in serum, transepidermal water loss (TEWL) and skin hydration were assessed. High-performance liquid chromatography/mass spectrometry (HPLC/MS) was used to determine the composition of WDE. Dermal application of 1% WDE grossly and histopathologically improved oxazolone- and DNCB-induced AD skin symptoms. Epidermal thickness and mast cell infiltration were significantly lower in animals treated with WDE than in vehicle controls. Furthermore, in addition to reducing DNCB-induced increases in serum IL-4 (interleukin 4) and IgE (immunoglobulin E) levels, WDE also decreased TEWL and increased skin hydration (indicative of improved skin barrier function). The four flavonoids taxifolin, aromadendrin, padmatin and chamaejasmine were tentatively identified in WDE by HPLC-DAD/QTOF-MS. The above results show WDE protected against oxazolone- and DNCB-induced AD in mice by down-regulating the T<sub>H</sub>2-associated cytokine IL-4 and improving skin barrier function and suggest WDE might be useful for the management of atopic dermatitis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, South Korea. jhjegal@pusan.ac.kr."}], "LastName": "Jegal", "ForeName": "Jonghwan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, South Korea. 115519@kist.re.kr."}], "LastName": "Park", "ForeName": "No-June", "Initials": "NJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, South Korea. taeyour@pusan.ac.kr."}], "LastName": "Kim", "ForeName": "Tae-Young", "Initials": "TY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, South Korea. decoy0@kribb.re.kr."}], "LastName": "Choi", "ForeName": "Sangho", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, South Korea. ethnolee@kribb.re.kr."}], "LastName": "Lee", "ForeName": "Sang Woo", "Initials": "SW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Plants, Yunnan Academy of Agricultural Sciences, Kunming 650205, China. jinhang1516@sina.com."}], "LastName": "Hang", "ForeName": "Jin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, South Korea. snkim@kist.re.kr."}], "LastName": "Kim", "ForeName": "Su-Nam", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Pusan National University, Busan 46241, South Korea. mhyang@pusan.ac.kr."}], "LastName": "Yang", "ForeName": "Min Hye", "Initials": "MH"}], "GrantList": [{"GrantID": "NRF-2016K1A1A8A01938595", "Agency": "NRF", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Dinitrochlorobenzene"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "15646-46-5", "NameOfSubstance": "Oxazolone"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "37341-29-0", "NameOfSubstance": "Immunoglobulin E"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Topical"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Dermatitis, Atopic"}, {"QualifierName": ["toxicity"], "DescriptorName": "Dinitrochlorobenzene"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin E"}, {"QualifierName": ["blood"], "DescriptorName": "Interleukin-4"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Hairless"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["toxicity"], "DescriptorName": "Oxazolone"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Components, Aerial"}, {"QualifierName": ["administration & dosage", "chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Wikstroemia"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Weidinger S., Novak N. Atopic dermatitis. Lancet. 2016;387:1109\u20131122. doi: 10.1016/S0140-6736(15)00149-X.", "ArticleIdList": ["10.1016/S0140-6736(15)00149-X", "26377142"]}, {"Citation": "Guttman-Yassky E., Nograles K.E., Krueger J.G. Contrasting pathogenesis of atopic dermatitis and psoriasis\u2014Part I: Clinical and pathologic concepts. J. Allergy Clin. Immunol. 2011;127:1110\u20131118. doi: 10.1016/j.jaci.2011.01.053.", "ArticleIdList": ["10.1016/j.jaci.2011.01.053", "21388665"]}, {"Citation": "Carroll C.L., Balkrishnan R., Feldman S.R., Fleischer A.B., Jr., Manuel J.C. The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society. Pediatr. Dermatol. 2005;22:192\u2013199. doi: 10.1111/j.1525-1470.2005.22303.x.", "ArticleIdList": ["10.1111/j.1525-1470.2005.22303.x", "15916563"]}, {"Citation": "Boccardi D., D\u2019Auria E., Turati F., DI M.V., Sortino S., Riva E., Cerri A. Disease severity and quality of life in children with atopic dermatitis: PO-SCORAD in clinical practice. Minerva Pediatr. 2017;69:373\u2013380.", "ArticleIdList": ["26200523"]}, {"Citation": "Wollenberg A., Kraft S., Oppel T., Bieber T. Atopic dermatitis: Pathogenetic mechanisms. Clin. Exp. Dermatol. 2000;25:530\u2013534. doi: 10.1046/j.1365-2230.2000.00699.x.", "ArticleIdList": ["10.1046/j.1365-2230.2000.00699.x", "11122224"]}, {"Citation": "Renz H., Jujo K., Bradley K.L., Domenico J., Gelfand E.W., Leung D.Y. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J. Investig. Dermatol. 1992;99:403\u2013438. doi: 10.1111/1523-1747.ep12616114.", "ArticleIdList": ["10.1111/1523-1747.ep12616114", "1401997"]}, {"Citation": "Jujo K., Renz H., Abe J., Gelfand E.W., Leung D.Y. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J. Allergy Clin. Immunol. 1992;90:323\u2013331. doi: 10.1016/S0091-6749(05)80010-7.", "ArticleIdList": ["10.1016/S0091-6749(05)80010-7", "1527316"]}, {"Citation": "D\u2019Auria E., Banderali G., Barberi S., Gualandri L., Pietra B., Riva E., Cerri A. Atopic dermatitis: Recent insight on pathogenesis and novel therapeutic target. Asian Pac. J. Allergy Immunol. 2016;34:98\u2013108.", "ArticleIdList": ["27007830"]}, {"Citation": "Gonz\u00e1lez R., Ballester I., L\u00f3pez-Posadas R., Su\u00e1rez M.D., Zarzuelo A., Mart\u00ednez-Augustin O., Medina F.S.D. Effects of flavonoids and other polyphenols on inflammation. Crit. Rev. Food Sci. 2011;51:331\u2013362. doi: 10.1080/10408390903584094.", "ArticleIdList": ["10.1080/10408390903584094", "21432698"]}, {"Citation": "Cook N.C., Samman S. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. J. Nutr. Biochem. 1996;7:66\u201376. doi: 10.1016/0955-2863(95)00168-9.", "ArticleIdList": ["10.1016/0955-2863(95)00168-9"]}, {"Citation": "Di Carlo G., Mascolo N., Izzo A.A., Capasso F. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci. 1999;65:337\u2013353. doi: 10.1016/S0024-3205(99)00120-4.", "ArticleIdList": ["10.1016/S0024-3205(99)00120-4", "10421421"]}, {"Citation": "Robak J., Gryglewski R. Bioactivity of flavonoids. Pol. J. Pharmacol. 1996;48:555\u2013564.", "ArticleIdList": ["9112694"]}, {"Citation": "Jo B.G., Park N.J., Jegal J., Choi S., Lee S.W., Jin H., Kim S.N., Yang M.H. A new flavonoid from Stellera chamaejasme L., stechamone, alleviated 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in a murine model. Int. Immunopharmacol. 2018;59:113\u2013119. doi: 10.1016/j.intimp.2018.04.008.", "ArticleIdList": ["10.1016/j.intimp.2018.04.008", "29653408"]}, {"Citation": "Karuppagounder V., Arumugam S., Thandavarayan R.A., Sreedhar R., Giridharan V.V., Watanabe K. Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis. Drug Discov. Today. 2016;21:632\u2013639. doi: 10.1016/j.drudis.2016.02.011.", "ArticleIdList": ["10.1016/j.drudis.2016.02.011", "26905599"]}, {"Citation": "Choi J.K., Jang Y.H., Lee S., Lee S.R., Choi Y.A., Jin M., Choi J.H., Park J.H., Park P.H., Choi H., et al. Chrysin attenuates atopic dermatitis by suppressing inflammation of keratinocytes. Food Chem. Toxicol. 2017;110:142\u2013150. doi: 10.1016/j.fct.2017.10.025.", "ArticleIdList": ["10.1016/j.fct.2017.10.025", "29050978"]}, {"Citation": "Peterson B. Johan emanuel wikstrom, with historical notes on the genus Wikstroemia. Pac. Sci. 1996;50:77\u201383."}, {"Citation": "Lu C.L., Li Y.M., Fu G.Q., Yang L., Jiang J.G., Zhu L., Lin F.L., Chen J., Lin Q.S. Extraction optimisation of daphnoretin from root bark of Wikstroemia indica (L.) C.A. and its anti-tumour activity tests. Food Chem. 2011;124:1500\u20131506. doi: 10.1016/j.foodchem.2010.08.002.", "ArticleIdList": ["10.1016/j.foodchem.2010.08.002"]}, {"Citation": "Chen Y., Fu W.W., Sun L.X., Wang Q., Qi W., Yu H. A new coumarin from Wikstroemia indica (L.) C.A. Mey. Chin. Chem. Lett. 2009;20:592\u2013594. doi: 10.1016/j.cclet.2009.01.002.", "ArticleIdList": ["10.1016/j.cclet.2009.01.002"]}, {"Citation": "Geng L.D., Zhang C., Xiao Y.Q. Studies on the chemical constituents in stem rind of Wikstroemia indica. Zhongguo Zhong Yao Za Zhi. 2006;31:817\u2013819.", "ArticleIdList": ["17048664"]}, {"Citation": "Wang L.Y., Unehara T., Kitanaka S. Anti-inflammatory activity of new guaiane type sesquiterpene from Wikstroemia indica. Chem. Pharm. Bull. 2005;53:137\u2013139. doi: 10.1248/cpb.53.137.", "ArticleIdList": ["10.1248/cpb.53.137", "15635251"]}, {"Citation": "Hu K., Kobayashi H., Dong A., Iwasaki S., Yao X. Antifungal, antimitotic and anti-hiv-1 agents from the roots of Wikstroemia indica. Planta Med. 2000;66:564\u2013567. doi: 10.1055/s-2000-8601.", "ArticleIdList": ["10.1055/s-2000-8601", "10985087"]}, {"Citation": "Jung Y., Kim J.C., Park N.J., Bong S.K., Lee S., Jegal H., Jin L.T., Kim S.M., Kim Y.K., Kim S.N. Eupatilin, an activator of PPAR\u03b1, inhibits the development of oxazolone-induced atopic dermatitis symptoms in Balb/c mice. Biochem. Biophys. Res. Commun. 2018;496:508\u2013514. doi: 10.1016/j.bbrc.2018.01.098.", "ArticleIdList": ["10.1016/j.bbrc.2018.01.098", "29353040"]}, {"Citation": "Hussain Z., Thu H.E., Shuid A.N., Kesharwani P., Khan S., Hussain F. Phytotherapeutic potential of natural herbal medicines for the treatment of mild-to-severe atopic dermatitis: A review of human clinical studies. Biomed. Pharmacother. 2017;93:596\u2013608. doi: 10.1016/j.biopha.2017.06.087.", "ArticleIdList": ["10.1016/j.biopha.2017.06.087", "28686974"]}, {"Citation": "Nedoszytko B., Soko\u0142owska-Wojdy\u0142o M., Ruckemann-Dziurdzi\u0144ska K., Roszkiewicz J., Nowicki R.J. Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: Atopic dermatitis, psoriasis and skin mastocytosis. Postepy Dermatol. Alergol. 2014;31:84\u201391. doi: 10.5114/pdia.2014.40920.", "ArticleIdList": ["10.5114/pdia.2014.40920", "PMC4112246", "25097473"]}, {"Citation": "Egawa G., Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. J. Allergy Clin. Immunol. 2016;138:350\u2013358. doi: 10.1016/j.jaci.2016.06.002.", "ArticleIdList": ["10.1016/j.jaci.2016.06.002", "27497277"]}, {"Citation": "Boguniewicz M., Leung D.Y. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol. Rev. 2011;242:233\u2013246. doi: 10.1111/j.1600-065X.2011.01027.x.", "ArticleIdList": ["10.1111/j.1600-065X.2011.01027.x", "PMC3122139", "21682749"]}, {"Citation": "Lee H.J., Lee S.H. Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis. Allergy Asthma Immunol. Res. 2014;6:276\u2013287. doi: 10.4168/aair.2014.6.4.276.", "ArticleIdList": ["10.4168/aair.2014.6.4.276", "PMC4077953", "24991450"]}, {"Citation": "Simpson E.L., Chalmers J.R., Hanifin J.M., Thomas K.S., Cork M.J., McLean W.I., Brown S.J., Chen Z., Chen Y., Williams H.C. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J. Allergy Clin. Immunol. 2014;134:818\u2013823. doi: 10.1016/j.jaci.2014.08.005.", "ArticleIdList": ["10.1016/j.jaci.2014.08.005", "PMC4180007", "25282563"]}, {"Citation": "Hvid M., Vestergaard C., Kemp K., Christensen G.B., Deleuran B., Deleuran M. IL-25 in atopic dermatitis: A possible link between inflammation and skin barrier dysfunction? J. Allergy Clin. Immunol. 2011;131:150\u2013157. doi: 10.1038/jid.2010.277.", "ArticleIdList": ["10.1038/jid.2010.277", "20861853"]}, {"Citation": "Kubo A., Nagao K., Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Investig. 2012;122:440\u2013447. doi: 10.1172/JCI57416.", "ArticleIdList": ["10.1172/JCI57416", "PMC3266780", "22293182"]}, {"Citation": "Calixto J.B., Campos M.M., Otuki M.F., Santos A.R. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med. 2004;70:93\u2013103.", "ArticleIdList": ["14994184"]}, {"Citation": "Werner Y., Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm. Venereol. 1985;65:102\u2013105.", "ArticleIdList": ["2408409"]}, {"Citation": "Marsella R., Olivry T., Carlotti D.N. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Vet. Dermatol. 2011;22:239\u2013248. doi: 10.1111/j.1365-3164.2011.00967.x.", "ArticleIdList": ["10.1111/j.1365-3164.2011.00967.x", "21414049"]}, {"Citation": "Middleton E. Biological properties of plant flavonoids: An overview. Int. J. Pharmacogn. 1996;34:344\u2013348. doi: 10.1076/phbi.34.5.344.13245.", "ArticleIdList": ["10.1076/phbi.34.5.344.13245"]}, {"Citation": "Ross J.A., Kasum C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002;22:19\u201334. doi: 10.1146/annurev.nutr.22.111401.144957.", "ArticleIdList": ["10.1146/annurev.nutr.22.111401.144957", "12055336"]}]}], "History": [{"Year": "2019", "Month": "3", "Day": "13"}, {"Year": "2019", "Month": "4", "Day": "2"}, {"Year": "2019", "Month": "4", "Day": "19"}, {"Year": "2019", "Month": "4", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31018627", "PMC6521165", "10.3390/nu11040914", "nu11040914"]}}]}